A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors

NCT07256782 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

444

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: QLC5508
DRUG: QL1706
DRUG: Cisplatin/ Carboplatin
DRUG: QL2107
DRUG: Paclitaxel
DRUG: 5-fluorouracil (5-FU)
DRUG: Oxaliplatin

Sponsor

Qilu Pharmaceutical Co., Ltd.